MS vs RNXT · P/E 20, $344.27B cap vs rev $266.0K
Morgan Stanley (MS) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
MS does not have a complete income-statement cache yet.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the MS and RNXT stock pages for the full models.
Not investment advice.